Meiji Yasuda Asset Management Co Ltd. cut its stake in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 14.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 8,227 shares of the company’s stock after selling 1,413 shares during the quarter. Meiji Yasuda Asset Management Co Ltd.’s holdings in HCA Healthcare were worth $3,841,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds also recently modified their holdings of HCA. Palisade Asset Management LLC purchased a new stake in shares of HCA Healthcare during the third quarter valued at approximately $26,000. Holos Integrated Wealth LLC purchased a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $29,000. Ares Financial Consulting LLC purchased a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $31,000. JPL Wealth Management LLC purchased a new stake in shares of HCA Healthcare during the third quarter valued at approximately $33,000. Finally, Aventura Private Wealth LLC purchased a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $34,000. 62.73% of the stock is owned by hedge funds and other institutional investors.
HCA Healthcare Stock Performance
Shares of NYSE HCA opened at $394.40 on Friday. The stock has a market cap of $87.49 billion, a PE ratio of 13.56, a price-to-earnings-growth ratio of 1.24 and a beta of 1.18. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52. The stock has a fifty day moving average of $465.16 and a 200-day moving average of $483.61.
HCA Healthcare Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s payout ratio is presently 10.73%.
Wall Street Analysts Forecast Growth
Several equities analysts have weighed in on the company. Mizuho increased their price objective on HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a report on Wednesday, February 25th. Royal Bank Of Canada reduced their price objective on HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating for the company in a report on Monday, April 27th. UBS Group increased their price objective on HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a report on Monday, February 23rd. Truist Financial reduced their price objective on HCA Healthcare from $546.00 to $535.00 and set a “buy” rating for the company in a report on Monday, April 27th. Finally, Weiss Ratings lowered HCA Healthcare from a “buy (b)” rating to a “buy (b-)” rating in a report on Monday. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $515.77.
Check Out Our Latest Stock Analysis on HCA
HCA Healthcare Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Featured Stories
- Five stocks we like better than HCA Healthcare
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
